GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Retained Earnings (2009 - 2026)

Updated

Gsk (GSK) recorded Retained Earnings of $15.38 billion in the quarter ended Jun 30, 2026, up 31.1% from $11.74 billion a year earlier but down 1.6% from the prior quarter.

Analysis

Gsk (GSK) Retained Earnings (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk reported Retained Earnings of $13.46 billion, up 35.1% from the prior year.

  • Annual Retained Earnings has increased for three straight years, with a five-year compound annual growth rate of 9.2% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Retained Earnings came in at $9.97 billion in the year ended Dec 31, 2024 (+10.7%), $9 billion in the year ended Dec 31, 2023 (+66.8%), $5.4 billion in the year ended Dec 31, 2022 (-50.6%) and $10.93 billion in the year ended Dec 31, 2021 (+26.0%).
  • Quarterly Retained Earnings has ranged from $3.05 billion in the quarter ended Sep 30, 2022 to $15.63 billion in the quarter ended Mar 31, 2026 over the past five years.
  • On a year-over-year basis, Retained Earnings has increased for 12 consecutive quarters, with growth averaging 23.3% over the last eight quarters.
  • Peak year-over-year performance for Retained Earnings in the last five years was growth of 191.0% in the quarter ended Sep 30, 2023, against a decline of 71.5% in the quarter ended Sep 30, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $15.63 billion (quarter ended Mar 31, 2026), $13.58 billion (quarter ended Dec 31, 2025) and $13.52 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 171.67 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn -17.33 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 40.86 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 12.59 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 2.20 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 112.09 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn 15.38 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.38 Bn
Mar 31, 2026 15.63 Bn
Dec 31, 2025 13.58 Bn
Sep 30, 2025 13.52 Bn
Jun 30, 2025 11.74 Bn
Mar 31, 2025 10.46 Bn
Dec 31, 2024 10.01 Bn
Sep 30, 2024 10.64 Bn
Jun 30, 2024 10.83 Bn
Mar 31, 2024 10.07 Bn
Dec 31, 2023 8.98 Bn
Sep 30, 2023 8.89 Bn
Jun 30, 2023 8.03 Bn
Mar 31, 2023 6.87 Bn
Dec 31, 2022 5.12 Bn
Sep 30, 2022 3.05 Bn
Jun 30, 2022 12.37 Bn
Mar 31, 2022 12.93 Bn
Dec 31, 2021 10.71 Bn
Sep 30, 2021 10.73 Bn
API Access

Gsk Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=GSK&period=max&api_key=YOUR_API_KEY